Skip to main content
. 2026 Jul 10;15(7):864. doi: 10.3390/antiox15070864
ABCA1 ATP-binding cassette transporter A1
ABCG1 ATP-binding cassette transporter G1
AGEs Advanced glycation end products
ApoA1 Apolipoprotein A-I
ApoB Apolipoprotein B
ApoC-III Apolipoprotein C-III
ApoE Apolipoprotein E
ASCVD Atherosclerotic Cardiovascular Disease
CAD Coronary Artery Disease
CE Cholesteryl Esters
CEC Cholesterol efflux capacity
CETP Cholesteryl Ester Transfer Protein
CVD Cardiovascular Disease
DHCR24 3-β-Hydroxysteroid-Δ24 reductase
dHDL Dysfunctional high-density lipoprotein
eNOS Endothelial nitric oxide synthase
HDL High-Density Lipoprotein
HDL-C High-density lipoprotein cholesterol
IL-6 Interleukin-6
LCAT Lecithin Cholesterol Acyltransferase
LDL Low-Density Lipoprotein
LDL-C Low-density lipoprotein cholesterol
MACE Major adverse cardiovascular events
MDA Malondialdehyde
NLRP3 NOD-, LRR- and Pyrin Domain-containing Protein 3
NO Nitric oxide
oxLDL Oxidized Low-Density Lipoprotein
PAF-AH Platelet-activating factor acetylhydrolase
PAD Peripheral Artery Disease
PI3K Phosphatidylinositol 3-kinase
PLTP Phospholipid Transfer Protein
PON1 Paraoxonase 1
PTMs Posttranslational Modifications
RCT Reverse Cholesterol Transport
ROS Reactive Oxygen Species
SAA Serum Amyloid A
SDMA Symmetric Dimethylarginine
S1P Sphingosine-1-Phosphate
SR-BI Scavenger receptor class B type I
T2DM Type 2 Diabetes Mellitus
TG Triglyceride
TLR2 Toll-like Receptor 2
TNF-α Tumor Necrosis Factor-α
WWP2 WW Domain Containing E3 Ubiquitin Protein Ligase 2